Vitamin D may be a potentially modifiable factor to reduce dementia risk, study suggests ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

A new study links tau pathology to disrupted sleep in Alzheimer's disease. Sleep expert Dr. Wendy Troxel discusses how ...

A new study shows a potential association between levels higher vitamin D levels and lower levels of the Alzheimer's biomarker tau protein years later.

NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, has completed its Phase 2a clinical trial in Alzheimer's Disease (AD) patients.

The Brazilian content creator had a combined following of more than 8 million across her social media platforms ...

A new surgical procedure, cervical lymphatico-venous bypass, has shown to improve symptoms for those with mild to moderate Alzheimer’s disease. Read more at straitstimes.com. Read more at straitstimes ...

Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ...

A common vaccine millions take every year has been linked to 'significantly lower' dementia risk in elderly people. A large ...

Seniors who got a high-dose flu vaccine had a nearly 55% reduced risk of Alzheimer’s, researchers reported earlier this month ...

A large study has found that the vaccine is associated with a significantly lower risk of Alzheimer's disease ...

Compared with standard-dose shots, high-dose flu shots were associated with a lower risk for Alzheimer's dementia in the ...